Dr. Reddy's Laboratories Ltd. ADR Stock
There is an upward development for Dr. Reddy's Laboratories Ltd. ADR compared to yesterday, with an increase of €1.50 (2.210%).
Currently there is a rather positive sentiment for Dr. Reddy's Laboratories Ltd. ADR with 5 Buy predictions and 1 Sell predictions.
With a target price of 73 € there is a slightly positive potential of 5.04% for Dr. Reddy's Laboratories Ltd. ADR compared to the current price of 69.5 €.
Pros and Cons of Dr. Reddy's Laboratories Ltd. ADR in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dr. Reddy's Laboratories Ltd. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | 2.210% | 0.725% | 3.731% | 26.364% | 12.097% | 21.930% | 84.840% |
| Sihuan Pharmaceutical Holdings Group Ltd. | 12.200% | 12.195% | 16.949% | -22.034% | 0.730% | -77.000% | -69.333% |
| Almirall S.A. | 0.400% | 1.457% | 6.353% | -3.918% | 2.774% | -33.550% | - |
| Orion Corp. B | 0.220% | 0.892% | 9.531% | -15.322% | -8.099% | -1.550% | 21.681% |
Comments
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target raised by analysts at Barclays PLC from $75.00 to $80.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for RDY provided by MarketBeat
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for RDY provided by MarketBeat